Skip to main content
Porto

PMMNG logo

  • Home
  • PMMNG Meetings
    • PMMNG Monthly Meetings
    • Steering Committee Meetings
  • Myeloma Events
  • Our Members
  • Miles for Myeloma 5K
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Previous Meetings

  • May 2026 PMMNG Meeting:
  • April 2026 PMMNG Meeting: "Writing and Reflecting" by Christina Bach
  • March 2026 PMMNG Meeting: Open Discussion
  • February 2026 PMMNG Meeting - Update from ASH 2024 by Dr Edward Stadtmauer
  • January 2026 PMMNG Meeting: "Interpetting Multiple Myeloma Blood Tests" Presented by Dr. Kamran M Mirza
  • December 2025 PMMNG Meeting: Annual Year End Celebration
  • November 2025 PMMNG Meeting: Annual Health Insurance Navigation Session
  • October 2025 PMMNG Meeting -Special CAR-T Panel Discussion
  • September 2025 PMMNG Meeting - "HealthTree's Cure Hub" by Todd Foster and Open Discussion
  • August 2025 -- No PMMNG Meeting
  • July 2025 PMMNG Meeting - "Interpreting Test Results and Living with Multiple Myeloma" by Grace Allison and Open Discussion
  • June 2025 PMMNG Meeting - SparkCures Overview by Brian McMahon

February 2017: ASH 2016 Highlights

The February 11, 2017 program will be a presentation of highlights about Multiple Myeloma research and treatment from the recent annual ASH (American of Society of Hematology) meeting. Our speaker will be  Adam D. Cohen, MD, Assistant Professor and Director of Myeloma Immunotherapy at the Abramson Cancer Center of the U of Pennsylvania. He will also provide a general overview of how immunotherapy is being used in treating myeloma. Lunch will be provided by Takeda Pharmaceuticals.

Dr. Cohen's slides

Tags
meeting
pmmng
ash
research
treatment
upenn